NSIV member, CrowdComfort, was featured in the WSJ last week in an article about high tech approaches being used to resolve the constant battle around the office thermostat. In addition to reporting uncomfortable conditions, CrowdComfort’s app leverages crowd-sourced occupant feedback to improve safety and operations in workplaces, unlock efficiencies in facilities management and preventative maintenance, increase employee productivity, and more.
NSIV member, Cellanyx Diagnostics, was awarded the best prostate cancer biomarker poster presentation at the recent 2016 American Urological Association annual meeting. “Cellanyx is currently developing phenotypic tests to address an important unmet clinical need in prostate cancer risk stratification by providing quantitative assessment of tumor aggressiveness and metastatic potential that complements the standard-of-care Gleason pathology scores”, according to the press release.
The Elevator Pitch: Sell Them on Your Idea, Your Product, Your Company, You!
Atentiv Holdings, Inc., a NSIV graduate, has recently obtained a $3 million working capital term loan from MassDevelopment’s Emerging Technology Fund.
Sharp Edge Labs, a former NSIV member, and ORIG3N have recently announced an alliance that will help create patient-specific disease treatments.
Arctic Sand Technologies announced in late February the completion of a $19.3M Series B round. Targeting major segments of the $5B DC/DC power conversion market, Arctic Sand’s ICs today enable significantly more runtime, smaller batteries and thinner profile smartphones, tablets and Ultrabooks.
NSIV is featured in a special section in the 2015-2016 edition of The Index of the Massachusetts Innovation Economy, published annually by the Massachusetts Technology Collaborative’s Innovation Institute. The special analysis, “Collaborative Workspaces in the Commonwealth,” takes a look at the different types of spaces, how many of each, the services offered and shows some examples of each type. NSIV is highlighted as one of three cases studies more fully described.
The March Mass Innovation Night – #MIN84 – will feature 11 local entrepreneurs and NSIV’s CrowdComfort is one of them! The event is Tuesday, March 8th, 2016 6 pm-8:30 pm at District Hall in Boston.
RAN Biotechnologies is delighted for SafvE, one of its partner companies, who has just won a Catalyst Grant from Massachusetts Clean Energy Center for Water and Clean Energy Innovation. SafvE is a non-profit company working on implementing new technologies for water treatment and sanitization. RAN Biotechnologies provides SafvE with anti-microbial polymers and coatings. Congratulations SafvE!
Former NSIV member Atentiv is making news with an announcement that it has a game in clinical trials designed to be used instead of medication for kids with ADHD. “We’re not using chemicals to effect the neurons, we’re rewiring the circuit… that rewiring is learning,” said Eric Cordon, CEO of Atentiv. The medical game is called Attentive Therapeutics and application to the FDA for marketing approval is expected in 2017. A computer game called ATENTIVmynd Games is another product being developed to help any child with attention issues. Watch for it to be released sometime later this year.